These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 28950924)

  • 1. Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis.
    Kohler PP; Volling C; Green K; Uleryk EM; Shah PS; McGeer A
    Infect Control Hosp Epidemiol; 2017 Nov; 38(11):1319-1328. PubMed ID: 28950924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
    J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae infections are associated with higher mortality compared to carbapenem-susceptible K. pneumoniae infections in the intensive care unit: a retrospective cohort study.
    Yao Y; Zha Z; Li L; Tan H; Pi J; You C; Liu B
    J Hosp Infect; 2024 Jun; 148():30-38. PubMed ID: 38513959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia.
    Ariffin H; Navaratnam P; Mohamed M; Arasu A; Abdullah WA; Lee CL; Peng LH
    Int J Infect Dis; 2000; 4(1):21-5. PubMed ID: 10689210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Carbapenem-resistant
    Wang Z; Qin RR; Huang L; Sun LY
    Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study.
    Cienfuegos-Gallet AV; Ocampo de Los Ríos AM; Sierra Viana P; Ramirez Brinez F; Restrepo Castro C; Roncancio Villamil G; Del Corral Londoño H; Jiménez JN
    BMC Infect Dis; 2019 Oct; 19(1):830. PubMed ID: 31590648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013.
    Hoxha A; Kärki T; Giambi C; Montano C; Sisto A; Bella A; D'Ancona F;
    J Hosp Infect; 2016 Jan; 92(1):61-6. PubMed ID: 26319590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
    Micozzi A; Gentile G; Minotti C; Cartoni C; Capria S; Ballarò D; Santilli S; Pacetti E; Grammatico S; Bucaneve G; Foà R
    BMC Infect Dis; 2017 Mar; 17(1):203. PubMed ID: 28283020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study.
    Simkins J; Muggia V; Cohen HW; Minamoto GY
    Transpl Infect Dis; 2014 Oct; 16(5):775-82. PubMed ID: 25092500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients.
    Pouch SM; Kubin CJ; Satlin MJ; Tsapepas DS; Lee JR; Dube G; Pereira MR
    Transpl Infect Dis; 2015 Dec; 17(6):800-9. PubMed ID: 26341757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy.
    Lee NY; Tsai CS; Syue LS; Chen PL; Li CW; Li MC; Ko WC
    Clin Ther; 2020 Mar; 42(3):e33-e44. PubMed ID: 32061374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.
    Jiao Y; Qin Y; Liu J; Li Q; Dong Y; Shang Y; Huang Y; Liu R
    Pathog Glob Health; 2015 Mar; 109(2):68-74. PubMed ID: 25707874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit.
    Vardakas KZ; Matthaiou DK; Falagas ME; Antypa E; Koteli A; Antoniadou E
    J Infect; 2015 Jun; 70(6):592-9. PubMed ID: 25447713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019.
    Hsu JY; Chuang YC; Wang JT; Chen YC; Hsieh SM
    J Formos Med Assoc; 2021 Nov; 120(11):1994-2002. PubMed ID: 33962811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia.
    Rodríguez OL; Sousa A; Pérez-Rodríguez MT; Martínez-Lamas L; Suárez RL; Martínez CT; Pino CP; Vidal FV; Pérez-Landeiro A; Casal MC
    Medicine (Baltimore); 2021 Apr; 100(14):e24880. PubMed ID: 33832068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
    Gomez-Simmonds A; Nelson B; Eiras DP; Loo A; Jenkins SG; Whittier S; Calfee DP; Satlin MJ; Kubin CJ; Furuya EY
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3601-7. PubMed ID: 27044555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae.
    Huang W; Qiao F; Zhang Y; Huang J; Deng Y; Li J; Zong Z
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S225-S230. PubMed ID: 30423052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.
    Zhang Y; Guo LY; Song WQ; Wang Y; Dong F; Liu G
    BMC Infect Dis; 2018 May; 18(1):248. PubMed ID: 29855274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study.
    Shilo S; Assous MV; Lachish T; Kopuit P; Bdolah-Abram T; Yinnon AM; Wiener-Well Y
    Infection; 2013 Apr; 41(2):503-9. PubMed ID: 23271210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections.
    Agyeman AA; Bergen PJ; Rao GG; Nation RL; Landersdorfer CB
    Int J Antimicrob Agents; 2020 Jan; 55(1):105833. PubMed ID: 31730892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.